Elantan Retard

Elantan Retard Brand names, Elantan Retard Analogs

Elantan Retard Brand Names Mixture

No information avaliable

Elantan Retard Chemical_Formula

C₆H₉NO₆

Elantan Retard RX_link

http://www.rxlist.com/cgi/generic/isomono2.htm

Elantan Retard fda sheet

http://www.fda.gov/cder/foi/anda/98/75-147_Isosorbide.htm

Elantan Retard msds (material safety sheet)

Elantan_Retard MSDS

Elantan Retard Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Elantan Retard Molecular Weight

191.139 g/mol

Elantan Retard Melting Point

88-91^oC

Elantan Retard H₂O Solubility

1.07E+005 mg/L

Elantan Retard State

Solid

Elantan Retard LogP

-0.15

Elantan Retard Dosage Forms

Tablet (immediate release); Tablet (extended release)

Elantan Retard Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Elantan Retard Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Elantan Retard Absorption

100%

Elantan Retard side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD₅₀=mg/kg(orally in rat)

Elantan Retard Patient Information

Elantan Retard Organisms Affected

Humans and other mammals